BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24625069)

  • 1. Structure-activity relationship studies toward the discovery of selective apelin receptor agonists.
    Margathe JF; Iturrioz X; Alvear-Perez R; Marsol C; Riché S; Chabane H; Tounsi N; Kuhry M; Heissler D; Hibert M; Llorens-Cortes C; Bonnet D
    J Med Chem; 2014 Apr; 57(7):2908-19. PubMed ID: 24625069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist.
    Iturrioz X; Alvear-Perez R; De Mota N; Franchet C; Guillier F; Leroux V; Dabire H; Le Jouan M; Chabane H; Gerbier R; Bonnet D; Berdeaux A; Maigret B; Galzi JL; Hibert M; Llorens-Cortes C
    FASEB J; 2010 May; 24(5):1506-17. PubMed ID: 20040517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure.
    El Messari S; Iturrioz X; Fassot C; De Mota N; Roesch D; Llorens-Cortes C
    J Neurochem; 2004 Sep; 90(6):1290-301. PubMed ID: 15341513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a competitive apelin receptor (APJ) antagonist.
    Macaluso NJ; Pitkin SL; Maguire JJ; Davenport AP; Glen RC
    ChemMedChem; 2011 Jun; 6(6):1017-23. PubMed ID: 21560248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action.
    Murza A; Besserer-Offroy É; Côté J; Bérubé P; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Sarret P; Marsault É
    J Med Chem; 2015 Mar; 58(5):2431-40. PubMed ID: 25668242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure].
    Iturrioz X; El Messari S; De Mota N; Fassot C; Alvear-Perez R; Maigret B; Llorens-Cortes C
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):704-8. PubMed ID: 17928781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability.
    Murza A; Parent A; Besserer-Offroy E; Tremblay H; Karadereye F; Beaudet N; Leduc R; Sarret P; Marsault É
    ChemMedChem; 2012 Feb; 7(2):318-25. PubMed ID: 22170700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
    Japp AG; Newby DE
    Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
    Medhurst AD; Jennings CA; Robbins MJ; Davis RP; Ellis C; Winborn KY; Lawrie KW; Hervieu G; Riley G; Bolaky JE; Herrity NC; Murdock P; Darker JG
    J Neurochem; 2003 Mar; 84(5):1162-72. PubMed ID: 12603839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral cardiovascular actions of apelin in conscious rats.
    Kagiyama S; Fukuhara M; Matsumura K; Lin Y; Fujii K; Iida M
    Regul Pept; 2005 Feb; 125(1-3):55-9. PubMed ID: 15582714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity.
    Zhang Y; Maitra R; Harris DL; Dhungana S; Snyder R; Runyon SP
    Bioorg Med Chem; 2014 Jun; 22(11):2992-7. PubMed ID: 24755525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel small molecule agonist scaffold for the APJ receptor.
    Narayanan S; Maitra R; Deschamps JR; Bortoff K; Thomas JB; Zhang Y; Warner K; Vasukuttan V; Decker A; Runyon SP
    Bioorg Med Chem; 2016 Aug; 24(16):3758-70. PubMed ID: 27369451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects.
    Gerbier R; Alvear-Perez R; Margathe JF; Flahault A; Couvineau P; Gao J; De Mota N; Dabire H; Li B; Ceraudo E; Hus-Citharel A; Esteoulle L; Bisoo C; Hibert M; Berdeaux A; Iturrioz X; Bonnet D; Llorens-Cortes C
    FASEB J; 2017 Feb; 31(2):687-700. PubMed ID: 27815337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.
    Iturrioz X; Gerbier R; Leroux V; Alvear-Perez R; Maigret B; Llorens-Cortes C
    J Biol Chem; 2010 Oct; 285(42):32627-37. PubMed ID: 20675385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
    Fan X; Zhou N; Zhang X; Mukhtar M; Lu Z; Fang J; DuBois GC; Pomerantz RJ
    Biochemistry; 2003 Sep; 42(34):10163-8. PubMed ID: 12939143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
    Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
    Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
    Falcão-Pires I; Leite-Moreira AF
    Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac action of the first G protein biased small molecule apelin agonist.
    Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
    Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
    O'Carroll AM; Lolait SJ; Harris LE; Pope GR
    J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.